Bioventus (BVS) Total Current Liabilities (2020 - 2026)
Bioventus' (BVS) quarterly Total Current Liabilities came in at $148.1 million in Q1 2026, down 15.25% YoY from $174.8 million in Q1 2025, and down 7.66% on a QoQ basis from $160.4 million in Q4 2025.
Bioventus (BVS) Total Current Liabilities (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Total Current Liabilities data on file, last reported at $148.1 million in Q1 2026.
- Quarterly Total Current Liabilities fell 15.25% year-over-year to $148.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $148.1 million (down 15.25% YoY) and the FY2025 annual result came in at $160.4 million, down 23.77% from the prior year.
- Total Current Liabilities eased to $148.1 million in Q1 2026, from $160.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $304.0 million in Q4 2022 to a low of $148.1 million in Q1 2026.
- A 5-year average of $196.0 million and a median of $179.1 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 79.44% — and 2023, when it tumbled 44.22%.
- Tracing BVS's Total Current Liabilities over 5 years: stood at $304.0 million in 2022, then plunged by 42.27% to $175.5 million in 2023, then climbed by 19.89% to $210.4 million in 2024, then declined by 23.77% to $160.4 million in 2025, then decreased by 7.66% to $148.1 million in 2026.
- The last three Total Current Liabilities figures came in at $148.1 million (Q1 2026), $160.4 million (Q4 2025), and $161.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Bioventus | 970.53 Mn | 941.07 Mn | 105.67 Mn | 152.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 152.45 Mn |
| Mar 28, 2026 | 148.10 Mn |
| Dec 31, 2025 | 160.38 Mn |
| Sep 27, 2025 | 161.75 Mn |
| Jun 28, 2025 | 185.68 Mn |
| Mar 29, 2025 | 174.75 Mn |
| Dec 31, 2024 | 210.40 Mn |
| Sep 28, 2024 | 211.49 Mn |
| Jun 29, 2024 | 231.46 Mn |
| Mar 30, 2024 | 173.32 Mn |
| Dec 31, 2023 | 175.50 Mn |
| Sep 30, 2023 | 160.84 Mn |
| Jul 1, 2023 | 179.10 Mn |
| Apr 1, 2023 | 196.06 Mn |
| Dec 31, 2022 | 304.02 Mn |
| Oct 1, 2022 | 288.37 Mn |
| Jul 2, 2022 | 198.87 Mn |
| Apr 2, 2022 | 171.52 Mn |
| Dec 31, 2021 | 180.86 Mn |
| Oct 2, 2021 | 160.71 Mn |